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Abstract 
Pig renal membrane dipeptidase cDNA has been expressed in COS-1 cells. Directed mutagenesis was used to investigate the roles of some conserved 
histidyl and aspartyl residues. Mutation of His”’ to Arg, Lys or Leu results in complete abolition of enzyme activity, although the mutants are 
expressed at the cell-surface. Residues in a proposed motif (DHXDH; residues 269-273) for zinc binding have been mutated individually. Each 
retained activity comparable to that of the wild-type, excluding an essential role for components of this motif. The zinc-binding ligands in membrane 
dipeptidase therefore represent a novel domain for a metallopeptidase with His219 being one candidate. 
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1. Introduction 
Membrane dipeptidase (MDP; microsomal dipepti- 
dase; dehydropeptidase-I; EC 3.4.13.19) is a glyco- 
sylphosphatidylinositol (GPI)-anchored protein of the 
kidney brush border membrane. It was originally de- 
scribed as a renal enzyme that could hydrolyse a variety 
of dipeptides; glycyl-o-phenylalanine (Gly-o-Phe) com- 
monly being used as an assay substrate. The enzyme 
exhibits a number of other catalytic activities including 
the conversion of leukotriene D, to leukotriene E, and 
hydrolysis of the /Slactam antibiotic, imipenem (see [l] 
for review). All of these activities are blocked by the 
selective MDP inhibitor, cilastatin. Immobilized cilas- 
tatin has proved highly effective in affinity purification 
of MDP after solubilization of the enzyme by treatment 
with phosphatidylinositol-specific phospholipase C (PI- 
PLC) [2]. 
MDP exists as disulphide-linked homo-dimeric 
glycoprotein of subunit M, 47,000 in pig and subunit M, 
59,000 in human. The differences in size between the two 
species being entirely attributable to differences in 
N-linked glycosylation [2-4]. cDNAs encoding the pro- 
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phosphatidylinositol-specific phospholipase C; TBS, Tris-buffered 
saline. 
tein were originally isolated and sequenced from human 
placental and renal cDNA libraries [5] and from a pig 
kidney library [6]. The pig and human enzymes show 
extensive similarity, consisting of 409 and 411 residues, 
respectively. Both possess a cleavable N-terminal signal 
peptide and a highly hydrophobic sequence at the 
C-terminus which provides the signal for GPI-anchor 
attachment. Pig MDP has two N-linked glycosylation 
sites, also found in the human enzyme, but the latter 
contains two additional sites consistent with the greater 
extent of glycosylation in this species. 
MDP is a zinc metallopeptidase [7] containing 1 mol 
of Zn*’ per subunit [8]. However, it does not contain 
within its sequence the characteristic signature identified 
in many other Zn2’ metallopeptidases (HEXXH), in- 
cluding a peptidyldipeptidase (angiotensin converting 
enzyme; EC 3.4.15.1) [9-l 11. The inverse motif 
(HXXEH) seen in some other Zn”-metallopeptidases 
such as insulin-degrading enzyme [12] is also absent. 
Comparison of the human and pig MDP sequences with 
other Zn*’ enzymes [6,13] revealed a sequence (DHLDH; 
residues 269-273) highly similar to a sequence (DHTH) 
containing the active site Zn2’-ligands in Streptomyces 
afbus o-alanyl-o-alanyl-cleaving carboxypeptidase [ 141. 
The DHLDH motif in MDP is also conserved in the 
more recently cloned rat and mouse enzymes [15,16]. In 
the carboxypeptidase from S. albus, a further Zn*’ ligand 
is located 40 residues on the N-terminal side of the 
DHXH motif. We previously speculated that in MDP, 
His219, 50 residues N-terminal to the putative motif, may 
fulfill this role [6]. In the present work we have employed 
directed mutagenesis to explore the roles of these resi- 
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dues in the catalytic activity of MDP. Surprisingly, the 
dipeptidase DHLDH sequence does not appear to be 
required for catalytic activity, although His219 is essen- 
tial. Since the predicted amino acid sequence contains no 
other recognised zinc motif, this metallopeptidase must 
contain a novel zinc-binding domain in which His219 may 
be one of the important residues involved in zinc binding 
or catalysis. 
2. Materials and methods 
2.1. Materials 
T4 polynucleotide kinase was obtained from New England Biolabs. 
Sequenase kit (version 2.0) was from Amersham. [“S]daATP (loo0 
Cilmmol) was from New England Nuclear. Tissue culture media, 
serum, trypsin-EDTA, penicillin, streptomycin, L-glutamine, transfec- 
tion reagent (1ipofectAmine) and T4 DNA ligase were purchased from 
Gibco-BRL. The mammalian expression vector pEF-BbS was a gener- 
ous gift from Dr. S. Nagata (Osaka, Japan) [17]. Gly-n-Phe and bi- 
cinchoninic acid were obtained from Sigma. Cilastatin was a gift from 
Merck, Sharp and Dohme, Rahway, NJ, USA. Bacillus thuringiensis 
PI-PLC was a eift from Dr. M.G. Low (New York, USA). All other 
reagents were 01 analytical grade. 
2.2. Methods 
2.2.1. Cell culture. COS-I cells were cultured in DMEM supple- 
mented with 10% foetal calf serum (heat inactivated), 100 units/ml 
penicillin, 100 fig/ml streptomycin and 2 mM L-glutamine at 37°C in 
5% co,. 
2.2.2. Construction of the expression vector (pEF-MDP) and tran- 
sient expression in COS-I cells. The Bluescript SKII- plasmid contain- 
ing an insert of 1.4 kb encoding the cloned pig MDP (pER11) [6] was 
digested with EcoRI and a fragment of 1.4 kb was purified by agarose 
gel electrophoresis. The eukaryotic expression vector pEF-BOS [17] 
was digested at XbaI sites and the two fragments were ligated using 
standard cloning procedures [18]. The orientation of the insert relative 
to the pEF promoter was verified by SmaI and Sac1 digestions. The 
resulting plasmid (pEF-MDP) was used for transfection of COS-1 cells. 
For transient expression of pEF-MDP in COS-I cells, the cells were 
plated in 24-well plates at 33% conAuency or in 150 cm’ flasks at 
approx. 2 x lo6 cells per flask. After 24 h of growth, the cells were 
washed twice with OptI-Mem and transfected (0.2 pug DNA/well) by 
using 1ipofectAmine as cationic lipid (DNA : lipid, 1 : 10). The cells were 
incubated for 2 h and DMEM containing 10% foetal calf serum was 
added. After 24 h, the medium was replaced with fresh, and transient 
expression was assayed on the cell surface or in a solubilized membrane 
preparation 48 h after transfection. 
2.2.3. Preparation of membranefraction. Adherent cells were washed 
three times with phosphate-buffered saline (PBS), scraped from the 
plates and spun down (1000 x g, IO min). Subsequently, the pellet was 
resuspended in 50 mM HEPESINaOH, pH 7.5, containing 20 mM 
CaCI, and cells disrupted by using N, cavitation. After a brief centrif- 
ugation at 1000 x g, the supernatant was centrifuged at 100,000 x g 
for 1 h and the membrane pellet was resuspended in 50 mM HEPES/ 
NaOH, pH 7.5. Membranes were solubilized by incubation with 60 mM 
n-octyl-p-o-glucopyranoside for 1 h at 4°C and centrifuged at 
12,000 x g for 10 min. The solubilized membranes were stored in 
aliquots at -20°C. 
2.2.4. Assay of membrane dipeptidase activity. Solubilized mem- 
branes (IO ~1; 1.2 pg protein) were incubated in 0.1 M Tris/HCl, pH 
8.0, containing 3 mM Gly-o-Phe with or without the inhibitor cilastatin 
(0.3 mM) in a total volume of 100~1. After incubation for 3 h at 37”C, 
samples were boiled for 4 min and centrifuged at 12,000 x g for IO min 
at 4°C. The product, o-Phe, was resolved from the substrate and quan- 
tified by HPLC on apBondapak C,, column by using a linear gradient 
of 4.5530% acetonitrile in 0.08% H,PO, [19]. 
2.2.5. Site-directed mutagenesis. Site-directed mutagenesis was per- 
formed according to the method of Kunkel [20]. E. coli CJ236 was 
transformed with the plasmid pEF-MDP. From an ampicillin-resistant 
colony single-stranded DNA (containing uracil) was isolated using 
helper phage R408 (according to the standard protocol of Boehringer- 
Mannheim). All the mutagenic primers were designed to be anti-sense. 
For construction of the different mutants the following primers were 
used with the changes indicated in bold in parentheses: 
(H270LR): 5’-ATGTGGTCCAGG(AC)GATCTGCCACTT-3’ 
(H273LR): 5’-ACCTTCTTGATG(AC)GGTCCAGG-3’ 
(D272A) : 5’-ACCTTCTTGATGTG(M)CCAGGTGATCTGCCAC- 
TTGGGACAA3’ 
(D269A): 5’-GTCCAGGTG(M)TCTGCCACTTG 
(H270Q) : 5’-CTTGATGTGGTCCAGCT(G)ATCTGCCACT- 
TGGGA-3 ’ 
(H270K) : 5 ’ -GATGTGGTCCAG (C ) T (T ) ATCTGCC 
ACTT-3 ’ 
(H219K) : 5 ’ -TGTAGGCCGAGGA (C) T ( T ) GCTGAAGA- 
TGAC-3 ‘ 
(H219L) : 5’-GTAGGCCGAGGAG(A)GGCTGAAGAT-3’ 
(H219R) : 5’-GTAGGCCGAGGAG(C)GGCTGAAGAT-3’. 
Mutations were verified by DNA sequencing (at least three clones for 
each mutation). COS-1 cells were transfected with the mutated DNA 
(at least two samples for each point mutation) and enzyme activity was 
assayed 48 h after transfection. 
2.2.6. Immunocytochemistry. COS-I ceils were plated in 24-well 
plates (containing coverslips) and transfected with wild type, H219K 
or H219R mutant cDNAs. 48 h post-transfection, cells were prepared 
for immunofluorescence as described previously [21]. Cells were washed 
gently 3 times with warm PBS (37°C) and fixed at room temoerature 
in 4% parafonnaldehyde for 20 min. Subsequently the cells were 
washed 3 times with Tris-buffered saline (TBS) and blocked for 30 min 
in TBS containing 0.2% gelatin at room temperature. The cells were 
incubated with affinity purified anti-dipeptidase IgG (1:500 dilution) 
[2]. After an overnight incubation at 4”C, cells were washed and incu- 
bated for 30 min with goat anti-rabbit IgG conjugated with fluorescein 
isothiocyanate (FITC) (1: 50 dilution). After washing three times with 
TBS, the coverslips were mounted in vectashield (Vector Laboratories, 
Peterborough, UK) and viewed with a Leitz confocal microscope. 
2.2.7. Protein determination. Protein concentrations were deter- 
mined by the bicinchoninic acid method [22] using bovine serum albu- 
min as standard. 
3. Results and discussion 
MDP is a metalloenzyme which exhibits a variety of 
catalytic activities, including the ability to hydrolyse 
dipeptides as well as the j?-lactam antibiotic imipenem. 
In addition it is able to convert leukotriene D, to leukot- 
riene E,. We had previously isolated a cDNA clone en- 
coding MDP from a pig kidney cortex cDNA library [6]. 
The predicted amino acid sequence of the protein 
showed no significant similarity to any other protein in 
the database; not even with other metallopeptidases or 
j?-lactamases. The absence of the HEXXH motif typical 
of zinc peptidases has prompted us to examine whether 
the DHXXH motif (residues 269-273), similar to an 
identified zinc motif in a bacterial carboxypeptidase [14], 
was important for activity. Like MDP, this carboxypep- 
tidase is able to hydrolyse peptides in which the C-termi- 
nal amino acid is a o-isomer. We have therefore initiated 
a programme of directed mutagenesis of histidines-270 
and -273 and aspartates-269 and -272 to assess their 
importance for catalytic activity. The possible impor- 
tance of His-219 has also been evaluated. 
52 S. Keynan et al. IFEBS Letters 349 (1994) 50-54 
Fig. 1. Immunostaining of transfected COS-1 cells for membrane dipeptidase using FITC-fluorescence. Cells were prepared as described in section 
2. (A) Control cells; (B) wild-type MDP expressed in COS-1 cells. In (C) and (D) the staining was performed in cells which had been transfected 
with either mutant H219K (C) or H219R (D). All the four micrographs represent a composite image taken at all focal planes. Bar = 10 mm. 
3.1. Expression of wild type membrane dipeptidase in 3.2. Mutation of the DHXXH motif 
COS-I cells 
When wild-type MDP was transiently expressed in 
COS-1 cells using the mammalian expression vector 
pEF-BOS, high level expression of enzyme activity was 
achieved which exhibited the characteristics appropriate 
of a GPI-anchored protein. Expressed protein could be 
detected at the cell-surface immunocytochemically by 
using a polyclonal antibody to pig MDP [2] (Fig. 1B). 
Phase-separation i  Triton X-l 14 of membrane prepara- 
tions from the transfected cells showed that the protein 
partitioned into the detergent-rich phase, indicating am- 
phipathic character (Table 1). After PI-PLC treatment 
followed by phase-separation, MDP appeared predomi- 
nantly in the detergent-poor phase (Table 1) confirming 
cleavage of the GPI anchor by the phospholipase and 
release of a hydrophilic form of the enzyme. Expressed 
activity was fully sensitive to the MDP specific inhibitor, 
cilastatin, and cilastatin-sensitive activity was undetecta- 
ble in cells transfected with control plasmid (Table 2). 
Each histidine in the proposed motif was changed to 
leucine; additionally His270 was mutated to Gln and Lys 
and His273 to Arg. Aspartates-269 and -272 were changed 
to Ala. After verification by sequencing of at least two 
mutants for each mutation, the insert containing the 
open reading frame was subcloned into the wild-type 
vector and the mutant cDNAs were expressed in COS-1 
cells as described for wild-type MDP. All the mutants 
express MDP activity at levels approaching that of the 
wild-type (Table 2). The activity was cilastatin-sensitive 
(Table 2) with an identical I,, value to the wild-type 
enzyme (Fig. 2). A detergent-solubilized membrane frac- 
tion revealed similar activity to intact cells (data not 
shown) and all the mutants were releasable in a soluble 
form by PI-PLC treatment (Table 1). Immunoblotting of 
membrane fractions from cells expressing wild-type or 
mutant MDP all revealed a polypeptide of M, approx 
90,000 after SDS-PAGE under non-reducing conditions 
(data not shown). 
Table 1 ^_^ 
Phase separation in Triton X-l 14 of wild-type and His”” mutants of membrane dipeptidase 
Triton X-l 14 phase pEF-MDP 
(-PI-PLC) 
pEF-MDP 
(+PI-PLC) 
H270R 
(-PI-PLC) 
H270R 
(+PI-PLC) 
H270L 
(-PI-PLC) 
H270L 
(+PI-PLC) 
Detergent-rich phase 92.2 t 0.0 6.5 f 0.5 96.2 f 5.0 8.6 + 0.7 86.2 f 3.5 10.5 + 0.1 
Detergent-poor phase 7.8 f 0.5 93.5 f 0.0 3.8 f 1.9 91.4 f 3.1 13.8 + 0.3 89.5 f 8.2 
MDP activity was assayed in the membrane fraction (12.6pg) before and after PI-PLC treatment. In each case, the proportion of activity partitioning 
into the detergent-rich and detergent-poor fractions was assessed after Triton X-I 14 phase-separation [3]. COS-1 cells were transfected with each 
of the following plasmids: pEF-MDP, H270R or H270L. Membrane fractions from the cells (40 ~1) were diluted 1 : 3.5 into 50 mM HEPES/NaOH, 
pH 7.5. To half of the samples was added 1 unit of PI-PLC followed by incubation for 2 h at 37°C. Pre-condensed Triton X-l 14 was added to a 
final concentration of 1%. After 10 min of incubation at 4°C followed by 10 min incubation at 30°C the samples were centrifuged at 3000 x g for 
3 min at 25°C. The upper (detergent-poor) phase was separated from the detergent-rich phase and both phases were brought to the same volume. 
Aliquots (10~1) from each phase were taken for determination of MDP activity as described in section 2. The results are expressed as the percentage 
of total activity recovered and are the mean f S.E.M. of four determinations. 
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Table 2 
Cell-surface activity of wild-type membrane dipeptidase and of histidyl and aspartyl mutants expressed in COS-1 cells 
Transfected cells Mutated to Specific activity 
(nmol D-Phelminlmg) 
Specific activity + cilastatin 
(nmol o-Phe/min/mg) 
pEF-MDP 
Control cells 
H270L 
H270Q 
H270K 
H273L 
H273R 
D269A 
D272A 
H219R 
H219K 
H219L 
(wild-type) 
(CAC + CTC) 
(CAC + CAG) 
(CAC -+ AAG) 
(CAC + CTC) 
(CAC + CCC) 
(CAT + GCA) 
(GAC --f GCA) 
(CAC + CGC) 
(CAC + AAG) 
(CAC -+ CTC) 
19.9 f 0.6 
0.5 _+ 0.0 
16.4 f 2.6 
24.5 f 0.6 
10.0 f 1.0 
24.5 + 1.5 
23.1 f 1.1 
9.2 f 1.4 
9.2 + 0.8 
0.4 f 0.0 
0.4 f 0.0 
0.5 + 0.0 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.4 
0.5 
0.4 
0.4 
0.5 
Transfection and expression were performed as described in section 2. Cell-surface xpression was determined on 24-well plates 48 h after transfection. 
The cells were washed twice with PBS and assayed by addition of 200 ,uI 0.1 M Tris-HCI, pH 8.0, containing Gly-o-Phe (3 mM) as substrate. After 
2.5 h at 37°C the buffer was collected and the product (n-Phe) quantified by HPLC as described in section 2. Results are themean f S.E.M. of triplicate 
determinations where indicated. 
3.3. Mutation of Hi?19 
His219 was mutated to Leu, Lys or Arg. In all cases 
there was complete abolition of cilastatin-sensitive n- 
zyme activity. His219 may therefore be a critical residue 
involved in zinc-binding. As can be seen in Fig. 1 for the 
H219K and H219R mutants, the mutated protein is ex- 
pressed on the cell-surface (Fig. lC, D) with the same 
intensity as the wild-type (Fig. 1B). The staining had a 
punctate appearance and covered the entire surface of 
the membrane. 
3.4. General conclusions 
There are seven histidines and nine glutamates con- 
served in MDP between all species whose cDNA derived 
80 
‘;i 
5 
.g 6o 
> 
‘= 
0 40 
a 
20 
O- 
9 
Fig. 2. Cilastatin inhibition of expressed membrane dipeptidase activ- 
ity. Solubilized membranes (10 ~1; 1.6 pug) were incubated in a total 
volume of 100 ~1 in 0.1 M Tris-HCl, pH 8.0, containing 3 mM Gly-D- 
Phe. Cilastatin was present at the final concentrations indicated on the 
abscissa. The samples were incubated for 2 h at 37°C and n-Phe product 
was then determined by HPLC as described in section 2. The forms of 
MDP expressed were (o), pEF-MDP; (A), H270Q and (o), H273R. 
Activity of 100% represents 56.6 nmol D-Phe/min/mg protein. 
amino acid sequences have so far been isolated. We have 
ruled out the histidines and aspartates in the DHLDH 
motif, which is conserved in the human, pig, rat and 
mouse enzymes, as being critical to enzyme activity but 
the conserved His219 is essential for functional protein. A 
rabbit kidney 43 kDa protein which is 81% homologous 
with human MDP has been suggested as the rabbit hom- 
ologue of MDP [23], although the cDNA clone has not 
been expressed so its functional activity is unknown. This 
protein has a tyrosine residue in place of the second 
histidine (His2’j) of the motif. Our data would suggest 
that this change should not affect activity and would be 
consistent with the rabbit 43 kDa protein representing 
MDP, particularly since His”’ is conserved. The only 
other residue in MDP reported to date whose mutation 
abolishes activity is G1t.1’~~ [24]. It is clear from the pres- 
ent data that the zinc-binding ligands in MDP must rep- 
resent a novel motif for a metallopeptidase. 
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